Michael Saunders
Gastroenterology · Seattle, WANPI 1891873253
Payments from drug & device makers
Across 22 payments — averaging $550.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- Covidien LP$3K
- Ninepoint Medical, Inc.$1K
- Fujifilm Healthcare Americas Corporation$317
- Cook Medical LLC$160
- Olympus America Inc.$74
- plus $15 from 1 others
What the payments were for
- Speaking & faculty fees$9,82589%
- Food & beverage$1,18011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $7,104 |
| Covidien LP | 4 | $3,335 |
| Ninepoint Medical, Inc. | 1 | $1,100 |
| Fujifilm Healthcare Americas Corporation | 2 | $317 |
| Cook Medical LLC | 2 | $160 |
| Olympus America Inc. | 1 | $74 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evident$3,200
- EXALT$2,250
- SPYGLASS$2,250
- GENERAL - THERAPIES$2,125
- GENERAL - BILIARY DEVICES$279
- FUJIFILM$261
- AXIOS$114
- Beacon$101
How this compares
$12,105 in reported general payments places this provider in the 85th percentile of 447 gastroenterology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $111,325 |
| CreonLipase/Protease/Amylase | 39 | $67,241 |
| Lansoprazole | 12 | $5,066 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 36 | $2,406 |
| Lubiprostone | 18 | $2,286 |
| Omeprazole | 99 | $1,825 |
| Pantoprazole Sodium | 37 | $770 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 23 | $331 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $233 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $145 |
| Promethazine Hcl | 18 | $141 |
| Prednisone | 15 | $103 |
| Metoclopramide Hcl | 21 | $27 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Seattle
- Kris KowdleySeattle$5.9M
- Scott LeeSeattle$3.7M
- Timothy ZismanSeattle$3.3M
- James LordSeattle$1.9M
- Charles LandisSeattle$1.7M
- Asma SiddiqueSeattle$1.3M
- Karlee AuskSeattle$758K
- Andrew RossSeattle$687K
- Sravanthi ParasaSeattle$485K
- Lei YuSeattle$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.